$ELTP called 9/21/13
$0.16
a 5-bagger now.














Shares Outstanding 527,082,097 a/o Feb 05, 2014
Float Not Available






03/05/14 
7:30 AM EST Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study
for Abuse Deterrent Product ELI-200 - GlobeNewswire


Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201
2/18/2014 7:00:00 AM - GlobeNewswire

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2014
2/14/2014 9:49:00 AM - GlobeNewswire

Elite Pharmaceuticals, Inc. to Host Third Quarter Business Update Call on February 18, 2014
2/10/2014 3:26:00 PM - GlobeNewswire

Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Second Opioid Abuse Deterrent Product
1/14/2014 1:21:00 PM - GlobeNewswire

Elite Pharmaceuticals: Swinging For The Fences
12/18/2013 10:53:00 AM - Seeking Alpha